Kyungdong Pharm (011040)

Currency in KRW
5,110
+10(+0.20%)
Closed·
High dividend Yield
011040 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5,0705,140
52 wk Range
4,7006,270
Key Statistics
Bid/Ask
5,100.00 / 5,110.00
Prev. Close
5,100
Open
5,100
Day's Range
5,070-5,140
52 wk Range
4,700-6,270
Volume
65.76K
Average Volume (3m)
72.71K
1-Year Change
-13.3898%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
011040 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 14, 2026
EPS / Forecast
208.00 / --
Revenue / Forecast
52.26B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 651.04%
Dividend Yield
5.88%
Industry Median 1.07%
Annualized payout
300.00
Paid unevenly
5-Years Growth
-9.71%
Growth Streak

011040 Income Statement

Compare 011040 to Peers and Sector

Metrics to compare
011040
Peers
Sector
Relationship
P/E Ratio
8.4x8.1x−0.4x
PEG Ratio
0.030.040.00
Price/Book
0.6x0.7x2.6x
Price / LTM Sales
0.7x0.5x3.1x
Upside (Analyst Target)
-54.9%49.6%
Fair Value Upside
Unlock20.6%7.1%Unlock

Kyung Dong Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals in South Korea. The company offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, cardiovascular and dysplidemia, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, antihistamine, CNS, antiobesity, NVP, neuropathic, osteoporosis, respiratory, allergy, and arthrifuge categories. It also provides OTC medicines for pain/inflammation, cardiovascular, hepatic protectors, combined metabolic agents, respiratory, gastrointestinal, calcium agent, vitamins and minerals, antihistamine, antifungal, antibiotic, otorhinolarynglogy agent, anti-inflammatory enzyme, dermatologic, hair solvents, capillary stabilizing agents, antiviral, tonics, and contraceptive categories; and health functional foods, quasi drugs, and APIs. The company was formerly known as Yuil Trading Company and changed its name to Kyung Dong Pharmaceutical Co., Ltd. in February 1976. Kyung Dong Pharmaceutical Co., Ltd. was founded in 1975 and is based in Gwacheon-si, South Korea.

Employees
350

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
149.65K0.56%757.24M
Other Institutional Investors
3.02M11.20%15.26B
Public Companies & Retail Investors
23.78M88.25%120.31B
Total
26.94M100.00%136.33B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kyung Dong Songcheon Foundation5.74%1,547,6587,831,149
Kyung Dong Labor Welfare Fund4.49%1,210,0006,122,600

People Also Watch

92,600
000640
-1.49%
157,000
000250
+1.03%
21,600
086450
-0.92%
31,800
214150
+0.32%
240,500
267250
+12.65%

FAQ

What Is the Kyungdong Pharm (011040) Stock Price Today?

The Kyungdong Pharm stock price today is 5,110 KRW.

What Stock Exchange Does Kyungdong Pharm Trade On?

Kyungdong Pharm is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Kyungdong Pharm?

The stock symbol for Kyungdong Pharm is "011040."

Does Kyungdong Pharm Pay Dividends? What’s The Current Dividend Yield?

The Kyungdong Pharm dividend yield is 5.88%.

What Is the Kyungdong Pharm Market Cap?

As of today, Kyungdong Pharm market cap is 149.43B KRW.

What Is Kyungdong Pharm's Earnings Per Share (TTM)?

The Kyungdong Pharm EPS (TTM) is 651.

When Is the Next Kyungdong Pharm Earnings Date?

Kyungdong Pharm will release its next earnings report on Aug 19, 2025.

From a Technical Analysis Perspective, Is 011040 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Kyungdong Pharm Stock Split?

Kyungdong Pharm has split 6 times.

How Many Employees Does Kyungdong Pharm Have?

Kyungdong Pharm has 350 employees.

What is the current trading status of Kyungdong Pharm (011040)?

As of Sep 04, 2026, Kyungdong Pharm (011040) is trading at a price of 5,110 KRW, with a previous close of 5,100 KRW. The stock has fluctuated within a day range of 5,070 KRW to 5,140 KRW, while its 52-week range spans from 4,700 KRW to 6,270 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.